Generative AI in Action: From Accelerating Drug Development to Enhancing Customer Insights and Operations
Listen now
Description
In episode 44, the conversation begins with an exploration of current generative AI trends and how they differ from traditional machine learning approaches. The episode highlights the innovative use of generative AI by companies like Pfizer and Takeda to accelerate drug development and clinical trials. It also features success stories from CogniSure and Comcast, focusing on enhancing customer insights and improving call center responses. The discussion continues with CMA CGM and Dick’s Sporting Goods leveraging AI for dynamic pricing and personalized marketing strategies. Insights from McKinsey and Accenture demonstrate how generative AI is streamlining operations. The episode concludes with a wrap-up of these transformative use cases.
More Episodes
In episode 59, we begin with an introduction to the challenges and opportunities of unstructured data in financial services. The discussion highlights how AI can support investment decisions and automate compliance processes, enhancing efficiency and accuracy. We explore AI's role in improving...
Published 11/25/24
In episode 58, we start with a welcome and an introduction to the episode's themes. We explore AI spending trends and the transformative effect on enterprises, followed by a discussion on generative AI use cases and the build vs. buy debate. The conversation shifts to AI implementation, focusing...
Published 11/21/24
Published 11/21/24